Merit Financial Group’s TG Therapeutics TGTX Stock Holding History

Merit Financial Group’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$250K	Buy	+4,550	New	+$186K	﹤0.01%	1945

Other funds holding TGTX

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Merit Financial Group's TGTX Position: Q2 2026 in Review

Merit Financial Group opened a new position in TG Therapeutics (TGTX) in Q2 2026: 4,550 shares worth $250K. The stake represents ﹤0.01% of the portfolio and ranks #1945 among its holdings.

61 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Merit Financial Group held 4,550 shares of TG Therapeutics worth $250K as of Q2 2026.
TG Therapeutics was a new Merit Financial Group position in Q2 2026.
TG Therapeutics made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1945 holding.
61 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.